QTMeds

Drug Database Monograph

RYBREVANT 350 mg

PENDING REVIEW

Active Ingredient: AMIVANTAMAB

QTc Interval Status:

neutral

Clinical Description (Database Summary)

Scientific Sources / References

Analyse RCP (Automatique), id : 61371536

← Back to Prescription Analyzer